Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ResistanceBio
AddedFeb 15, 2024
UpdatedJul 3, 2026
ResistanceBio

ResistanceBio

Closed

Resistance Bio aids in combating treatment-resistant cancer through pre-clinical discovery and solutions.

HQ
San Carlos, CA, US
Founded
2016
Accelerator
Y Combinator logoY CombinatorW19
Overview
Compare
Fundraising
Employees
News

Founded with a mission to combat treatment-resistant cancer, ResistanceBio focuses on pre-clinical discovery and solutions to overcome clinical treatment resistance. The company leverages a unique platform that generates real resistance data, aiming to provide innovative solutions for patients who do not respond to conventional cancer treatments. By addressing a critical gap in cancer therapy, ResistanceBio targets a specialized market of healthcare providers and researchers dedicated to improving cancer treatment outcomes.

ResistanceBio has garnered attention for its pioneering approach and has attracted notable investors and experts in the oncology field. The company's key achievements include developing a robust platform that offers actionable insights into drug resistance, potentially transforming the landscape of cancer treatment. Through its innovative solutions, ResistanceBio has made a significant impact on the fight against treatment-resistant cancer, offering hope to patients and advancing the capabilities of modern oncology.

ResistanceBio - Similar Companies

Serinus Biosciences logo

Serinus Biosciences

serinus.bio

Viosera Therapeutics logo

Viosera Therapeutics

Alixia logo

Alixia

alixia.com

First Ascent Biomedical logo

First Ascent Biomedical

firstascentbio.com

Vivacitas Oncology logo

Vivacitas Oncology

vivaoncology.com

Empiri logo

Empiri

empiricancer.com

Asher Bio logo

Asher Bio

asherbio.com

EtiraRx logo

EtiraRx

etirarx.com

Oncobox logo

Oncobox

oncobox.com

OncoResponse logo

OncoResponse

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Kurome Therapeutics logo

Kurome Therapeutics

Tradewind BioScience logo

Tradewind BioScience

tradewindbio.com

Duet BioTherapeutics logo

Duet BioTherapeutics

ResistanceBio - Quick Facts

Who are ResistanceBio's competitors?

Companies similar to ResistanceBio include Serinus Biosciences, Viosera Therapeutics, Alixia and First Ascent Biomedical.

When was ResistanceBio founded?

ResistanceBio was founded in 2016.

Where is ResistanceBio's headquarters located?

ResistanceBio's headquarters is located in San Carlos, CA, US.

When was ResistanceBio's last funding round?

ResistanceBio's most recent funding round was for $12.8M (USD) in January 2024.

How much has ResistanceBio raised to-date?

As of Jan 29, 2024, ResistanceBio has raised a total of $24.8M (USD).

ResistanceBio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Cancer Treatment
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified